Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAIC”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Large-scale testing (Phase 3)UnknownNCT01214343
What this trial is testing

Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC

Who this might be right for
Advanced Hepatocellular CarcinomaCarcinomaCarcinoma, Hepatocellular+2 more
Ministry of Health, Labour and Welfare, Japan 190
Testing effectiveness (Phase 2)Looking for participantsNCT06370065
What this trial is testing

Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Advanced Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 35
Testing effectiveness (Phase 2)Looking for participantsNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02981498
What this trial is testing

Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 35
Testing effectiveness (Phase 2)UnknownNCT04947826
What this trial is testing

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Shanghai Zhongshan Hospital 100
Not applicableNot Yet RecruitingNCT06423144
What this trial is testing

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 150
Early research (Phase 1)UnknownNCT05533892
What this trial is testing

Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Wan-Guang Zhang 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Testing effectiveness (Phase 2)UnknownNCT05886465
What this trial is testing

HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 40
Not applicableUnknownNCT05621499
What this trial is testing

HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Not applicableLooking for participantsNCT06632093
What this trial is testing

HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatic Arterial Infusion Chemotherapy+3 more
First Hospital of China Medical University 84
Large-scale testing (Phase 3)Ended earlyNCT05171166
What this trial is testing

Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

Who this might be right for
Hepatocellular Carcinoma
Peking University 18
Testing effectiveness (Phase 2)UnknownNCT05877001
What this trial is testing

The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Peking University Cancer Hospital & Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06406634
What this trial is testing

Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hunan Cancer Hospital 30
Post-approval studies (Phase 4)Looking for participantsNCT06311942
What this trial is testing

Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.

Who this might be right for
HCC
Chen Xiaoping 300
Testing effectiveness (Phase 2)UnknownNCT05311319
What this trial is testing

HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection

Who this might be right for
Hepatocarcinoma
Fudan University 70
Testing effectiveness (Phase 2)Study completedNCT03048123
What this trial is testing

HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 79
Not applicableStudy completedNCT07272265
What this trial is testing

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 300
Load More Results